Brimonidine tartarate

CAS: 70359-46-5

Ref. IN-DA0069OY

Informação sobre produto

• Nome: Brimonidine tartarate
• Sinónimos: [u'5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate', u'5-bromo-6-(imidazolidinylideneamino)quinoxaline', u'5-bromo-6-(imidazolin-2-ylamino)quinoxaline', u'AGN 190342', u'AGN-190342', u'AGN190342', u'Alphagan', u'Alphagan P', u'brimonidine', u'brimonidine Purite', u'brimonidine tartrate', u'brimonidine tartrate (1:1)', u'brimonidine tartrate (1:1), (S-(R*,R*))-isomer', u'brimonidine tartrate, (R-(R*,R*))-isomer', u'bromoxidine', u'mirvaso', u'Ratio Brimonidine', u'ratio-Brimonidine', u'Sanrosa', u'UK 14,304', u'UK 14,304 18', u'UK 14,304-18', u'UK 14,30418', u'UK 14,308', u'UK 14304', u'UK 14308', u'UK-14,304-18', u'UK-14,308', u'UK-14304', u'UK14,30418', u'UK14,308', u'UK14304', u'BRIMONIDINE TARTRATE', u'70359-46-5', u'Brominide tartrate', u'Alphagan', u'Brimonidine D-tartrate', u'UNII-4S9CL2DY2H', u'Brimonidinne tartrate', u'C11H10BrN5.C4H6O6', u'Brimonidine L-Tartrate', u'Brimonidine (tartrate)', u'Brimonidine D-tartarate', u'4S9CL2DY2H', u'5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxysuccinate', u'UK-14304-18', u'Qoliana', u'(5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1h-imidazol-2-yl)-amine L-tartrate', u'brimonidine Purite', u'5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine; (2R,3R)-2,3-dihydroxybutanedioic acid', u'59803-99-5', u'Brimonidine tartrate [USAN]', u'AGN-190342-LF', u'Alphagan-P', u'AGN 190342LF', u'Brimonidine tartrate [USAN:JAN]', u'N-(5-bromoquinoxalin-6-yl)imidazolidin-2-imine;(2R,3R)-2,3-dihydroxybutanedioic acid', u'Alphagan (TN)', u'brimonidine-tartrate', u'5-bromo-N-', u'UK14304 tartrate', u'AC1L1GYC', u'AGN190342 tartrate', u'AC1Q59OR', u'UK 14,304 (tartrate)', u'SCHEMBL265607', u'HY-B0659A', u'Brimonidine tartrate (JAN/USAN)', u'HMS3715P18', u'AGN 190342-LF', u'ACT08633', u'EBD23481', u'KS-00000K6V', u'MFCD07773072', u'AKOS016845265', u'CCG-221278', u'CS-4496', u'Brimonidine tartrateUK 14,304 tartrate', u'AN-12800', u'AS-18083', u'AB0021226', u'LS-177484', u'ST24046243', u'W0014', u'A19740', u'D02076', u'359B465', u'brimonidine tartrate (1:1), (S-(R*,R*))-isomer', u'(4,5-Bihydro-1H-imidazol-2-yl)quinoxalin-6-amine L-tartrate', u'5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl) quinoxalin-6-amine tartrate', u'5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine L-Tartrate', u'6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)', u'6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1)', u'brimonidine', u'Alphagan P', u'mirvaso', u'Lumify', u'UK 14,304 tartrate', u'D00ARM', u'CID54405', u'CS-O-03921', u'C11-H10-Br-N5.C4-H6-O6', u'5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline', u'A13433', u'Brimonidine tartrate, 98.5% - 100MG 100mg', u'79570-19-7', u'5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate (1:1)', u'5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate', u'59803-98-4', u'5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine(2R,3R)-2,3-dihydroxysuccinate', u'6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)'], (5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine L-tartrate, 5-Bromo-N-(4,5-Dihydro-1H-Imidazol-2-Yl)-6-Quinoxalinamine Tartrate, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine 2,3-dihydroxybutanedioate (1:1), 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine 2,3-dihydroxybutanedioate (salt), 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1), 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1), Agn 190342Lf, Alphagan, Alphagan P, Brimonidine Purite, Brimonidine tartrate, Brominide tartrate, Mirvaso
• Marca: Indagoo

Propriedades químicas

• Peso molecular: 442.2214
• Fórmula: C₁₅H₁₆BrN₅O₆
• Pureza: 99%
• Cor/forma: Solid
• InChI: InChI=1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
• Chave InChI: QZHBYNSSDLTCRG-LREBCSMRSA-N